Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Category: Providers
A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Hawaii, North Dakota, Oklahoma and Oregon have joined the quickly growing list of states to introduce 340B contract pharmacy access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
French pharmaceutical giant Sanofi has reinstated its 340B contract pharmacy restrictions in Kansas and West Virginia following legal developments in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B drug discount program continued to be a hot topic for lobbyists in the final quarter of 2024, keeping [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Yesterday’s New York Times investigative article alleging that the 340B prime vendor, Apexus, profited by driving 340B program expansion has [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Lawmakers in Nebraska and New York have reintroduced 340B contract pharmacy access bills this week after their state legislatures failed [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) has terminated the 340B status of 20 sites affiliated with the Nevada-based STD [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An influential New Mexico lawmaker is once again pushing to protect state 340B providers from drugmaker contract pharmacy restrictions after [...] …